TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

Effective TIL Therapy for Patients with Checkpoint-Resistant Melanoma without Lymphodepleting Regimens Requires IFNα.

Els M E Verdegaal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.